Intellectual Property Magazine

Antitrust class action filed against AbbVie’s $20bn Humira blockbuster

A class action lawsuit has been filed against drug makerAbbVie et al over allegations toblock competition for its blockbuster drug Humira in the US.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.